Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approvals
Pharma
Geopolitical tensions, Carvykti, Enhertu—Fierce Pharma Asia
Geopolitical tension clouds over China's biotech deals. Carvykti and Enhertu snagged new approvals. Fujifilm invests $1.2 billion in its NC facility.
Angus Liu
Apr 12, 2024 8:20am
J&J, Legend's Carvykti quickly leaps ahead of BMS' rival CAR-T
Apr 8, 2024 8:30am
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Mar 22, 2024 8:45am
Bristol Myers bags FDA nod to bring CAR-T to CLL
Mar 15, 2024 9:46am
BeiGene finally snags FDA approval for PD-1 drug Tevimbra
Mar 15, 2024 8:39am
FDA approves first drug for MASH in Madrigal's Rezdiffra
Mar 14, 2024 3:56pm